Gender dysphoria—prevalence and co-morbidities in an Irish adult population. Many transgender women may be unable or unwilling to quit smoking; this should not represent an absolute contraindication to estrogen therapy. If the informed consent process is properly documented in the chart, consent forms do not likely provide any additional legal protections to the provider. Is progestin an independent risk factor for incident venous thromboembolism? Abstract Transgender women experience lifelong gender dysphoria due to a gender assignment at birth that is incongruent with their gender identity. Requires monitoring of potassium Has diuretic and antihypertensive effect.
Treatment of postmenopausal women with oestrogen, with or without progesterone, has been associated with an increase in triglycerides and HDL cholesterol and a decrease in total and LDL cholesterol.
Max single patch dose available is mcg. Facial feminization surgery: The physician responsible for endocrine treatment should medically clear transsexual individuals for sex reassignment surgery and collaborate with the surgeon regarding hormone use during and after surgery.
Special considerations Gender-reaffirming surgery Cross-sex hormone treatment affects secondary sex characteristics of transgender women, making them more feminine in appearance; however, it has little effect on the primary sex organs except to cause some testicular atrophy.